Patents by Inventor Chris FRANGIEH

Chris FRANGIEH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240294643
    Abstract: Methods of targeting CD58 signaling to enhance antitumor immunity and overcome resistance to checkpoint blockade therapy. Gene signatures associated with immune fitness were identified. Markers and therapeutic targets for such immunotherapy resistance.
    Type: Application
    Filed: February 2, 2024
    Publication date: September 5, 2024
    Applicants: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, Massachusetts Institute of Technology, The Broad Institute, Inc.
    Inventors: Benjamin IZAR, Johannes C. MELMS, Pratiksha THAKORE, Katie GEIGER-SCHULLER, Aviv REGEV, Chris FRANGIEH
  • Publication number: 20220002416
    Abstract: Methods of targeting CD58 signaling to enhance antitumor immunity and overcome resistance to checkpoint blockade therapy. Gene signatures associated with immune fitness were identified. Markers and therapeutic targets for such immunotherapy resistance.
    Type: Application
    Filed: June 28, 2021
    Publication date: January 6, 2022
    Inventors: Benjamin IZAR, Johannes C. MELMS, Pratiksha Thakore, Katie GEIGER-SCHULLER, Aviv REGEV, Chris FRANGIEH